VASCULAR INNOVATIONS IN 2025: WHAT'S NEXT, AND WHAT'S REAL? (Non-CME)

Moderator(s)

• 

  Gary Ansel, MD

  Assistant Clinical Professor
  University of Toledo
  Interventional Cardiology
  Columbus, Ohio, United States

  Disclosure information pending.
• 

  Tony Das, MD

  Chief, Cardiovascular Strategic Planning, Innovation, Digital Health, and Endovascular Intervention
  Baylor Scott & White Heart Hospital
  Interventional Cardiology
  Dallas, Texas, United States

  Disclosure information pending.

Panel(s)

• 

  Kathleen Gibson, MD

  Partner
  Lake Washington Vascular Surgeons
  Vascular Surgery
  Bellevue, Washington, United States

  Disclosure(s): BD (formerly Bard): Grants/Research Support Recipient
  Boston Scientific: Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Gore and Associates: Consultant
  Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Koya: Consultant
  Medtronic: Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Philips: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Vesper: Grants/Research Support Recipient
• 

  Michael Jaff, DO

  Professor of Medicine (retired)
  Harvard Medical School
  Vascular Medicine
  Maple Grove, Minnesota, United States

  Disclosure(s): Access Vascular: Stockholder - Privately-held company
  Boston Scientific: Employee; Stockholder - Publicly-traded company (excludes mutual/index funds)
  Efemoral: Stockholder - Privately-held company
  Embolitech: Stockholder - Privately-held company
  Gilde Healthcare: Consultant
  Healthcare InRoads: Owner/Co-Owner, or Founder/Co-Founder
  Heartbeam: Stockholder - Publicly-traded company (excludes mutual/index funds)
  Janacare: Stockholder - Privately-held company
  Nectero: Stockholder - Privately-held company
  Primacea: Owner/Co-Owner, or Founder/Co-Founder
  R3 Vascular: Stockholder - Privately-held company
• 

  John Kaufman, MD

  Department of Interventional Radiology
  Oregon Health and Science University
  Interventional Radiology
  Portland, Oregon, United States

  Disclosure(s): Cook Medical: Employee
  MedyxAi: Consultant
  Shape Memory Medical: Stockholder - Privately-held company
  VuMedi: Stockholder - Privately-held company
• 

  John Laird, MD

  Interventional Cardiologist
  Adventist Health St. Helena
  Interventional Cardiology
  Napa, California, United States

  Disclosure(s): No relevant disclosure to display
• 

  Ben Starnes, MD

  Professor of Surgery; Division of Vascular Surgery
  University of Washington
  Vascular Surgery
  Seattle, Washington, United States

  Disclosure(s): Terumo Aortic: Consultant

Presentations:

• 3:45pm - 3:52pm PT

  Endovascular Therapies for Venous Congestion: The Next Frontier?
  

  Speaker: Kathleen Gibson, MD – Lake Washington Vascular Surgeons
• 3:52pm - 3:55pm PT

  Panel Discussion
• 3:55pm - 4:02pm PT

  No More Bailout: Can Smart Closure Devices Eliminate Femoral Complications?
  

  Speaker: Gary M. Ansel, MD – University of Toledo
• 4:02pm - 4:05pm PT

  Panel Discussion
• 4:05pm - 4:12pm PT

  Next-Gen Endografts: Can One Platform Serve Thoracic, Arch, and Abdominal Aorta?
  

  Speaker: Ben Starnes, MD – University of Washington
• 4:12pm - 4:15pm PT

  Panel Discussion
• 4:15pm - 4:22pm PT

  Disrupting DVT: Are We Overbuilding the Thrombectomy Toolbox?
  

  Speaker: John Kaufman, MD – Oregon Health and Science University
• 4:22pm - 4:25pm PT

  Panel Discussion
• 4:25pm - 4:32pm PT

  Microaccess, Microimplants: The Era of Ultra-Low-Profile Intervention
  

  Speaker: John Laird, MD – Adventist Health St. Helena
• 4:32pm - 4:35pm PT

  Panel Discussion
• 4:35pm - 4:42pm PT

  What’s Fueling the 2025 Pipeline? Trends, Gaps, and the Future of Vascular Device Funding
  

  Speaker: Michael Jaff, DO – Harvard Medical School
• 4:42pm - 4:45pm PT

  Panel Discussion